Aer Therapeutics is a series a startup. 1 investor tracked on Brouky Intelligence. Status: possibledead. Data sourced from Brouky Intelligence.
About
Developer of inhaled therapeutics designed to treat severe pulmonary diseases. The company's therapeutics focuses on diseases including pulmonary hypertension and cystic fibrosis, providing patients with targeted therapies to enhance the quality of life.
Stage
series-a
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky